Eugit Therapeutics

Private Company

Tissue targeting of therapies

Biotechnology Research
San Carlos, California
2-10 employees
Founded 2022

About Eugit Therapeutics

EugiaTx is a biotechnology company leveraging computational genomics and genome editing to develop tissue-targeting therapies. Its core offering is the TAGHOME platform, a targeted drug delivery system designed to enhance the safety and efficacy of treatments for inflammatory diseases. The company aims to form partnerships with other pharmaceutical and biotech firms to bring these advanced therapeutics to market.

Company Classification

Customer Types
B2B
Business Models
ProductsLicensing
Product & Service Types
Targeted Drug Delivery PlatformTherapeutic Development

Funding

Total Funding

$500.0K

No. of Funding Rounds

1

Sign up to Ethos to access the full customer list, plus detailed competitor and product analysis.

Sign up to Ethos